These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10716068)

  • 1. Biotransformation of BOF-4272, a sulfoxide-containing drug, in the cynomolgus monkey.
    Naito S; Nishimura M; Jin Y
    Eur J Drug Metab Pharmacokinet; 1999; 24(3):279-86. PubMed ID: 10716068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic pathways and pharmacokinetics of BOF-4272, a sulfoxide-containing drug, in the dog: in vivo and in vitro studies.
    Naito S; Nishimura M; Yoshitsugu H; Nogawa H
    Biol Pharm Bull; 1999 Dec; 22(12):1391-5. PubMed ID: 10746178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of the xanthine oxidase inhibitor BOF-4272 and its metabolites in the liver and by the intestinal flora in rat.
    Naito S; Nishimura M
    Xenobiotica; 2000 Jan; 30(1):103-9. PubMed ID: 10659955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies on the stereoselective pharmacokinetics and biotransformation of an (S)-(-)- and (R)-(+)-pyrazolotriazine sulfoxide in the male rat.
    Naito S; Nishimura M
    Xenobiotica; 2002 Jun; 32(6):491-503. PubMed ID: 12160482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, after single intravenous or oral administration to male mice and rats.
    Naito S; Nishimura M; Nogawa H
    J Pharm Pharmacol; 1999 Mar; 51(3):347-51. PubMed ID: 10344637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the pharmacological actions and pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, in mouse liver.
    Naito S; Nishimura M; Tamao Y
    J Pharm Pharmacol; 2000 Feb; 52(2):173-9. PubMed ID: 10714947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic properties of a novel xanthine oxidase inhibitor, BOF-4272, in healthy volunteers.
    Uematsu T; Nakashima M
    J Pharmacol Exp Ther; 1994 Aug; 270(2):453-9. PubMed ID: 8071837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of latanoprost in the cynomolgus monkey. 1st communication: single intravenous, oral or topical administration on the eye.
    Sjöquist B; Tajallaei S; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):225-33. PubMed ID: 10219466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of latanoprost in the cynomolgus monkey. 2nd communication: repeated topical administration on the eye.
    Sjöquist B; Uhlin A; Byding P; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):234-9. PubMed ID: 10219467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of mespirenone, a new aldosterone antagonist, in rat and cynomolgus monkey.
    Hildebrand M; Krause W; Kühne G; Hoyer GA
    Xenobiotica; 1987 May; 17(5):623-34. PubMed ID: 3604266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and disposition of [14C]brivanib alaninate after oral administration to rats, monkeys, and humans.
    Gong J; Gan J; Caceres-Cortes J; Christopher LJ; Arora V; Masson E; Williams D; Pursley J; Allentoff A; Lago M; Tran SB; Iyer RA
    Drug Metab Dispos; 2011 May; 39(5):891-903. PubMed ID: 21289073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of albumin on enantioselective local disposition of BOF-4272, a xanthine oxidase inhibitor with chiral sulfoxide, in rat liver.
    Nishimura M; Yamaoka K; Naito S; Nakagawa T
    Biol Pharm Bull; 1997 Dec; 20(12):1285-9. PubMed ID: 9448105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of the antidepressant D,L-rolipram. II. Metabolite patterns in man, rat, rabbit, rhesus and cynomolgus monkey.
    Krause W; Kühne G
    Xenobiotica; 1993 Nov; 23(11):1277-88. PubMed ID: 8310711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of NO-1886, a lipoprotein lipase-promoting agent, in cynomolgus monkey.
    Morioka Y; Harada M; Imai T; Naito S
    Xenobiotica; 2003 Dec; 33(12):1247-60. PubMed ID: 14742146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic parameters of tibolone and metabolites in plasma, urine, feces, and bile from ovariectomized cynomolgus monkeys after a single dose or multiple doses of tibolone.
    Verheul HA; Timmer CJ; van Iersel ML; Delbressine LP; Kloosterboer HJ
    Drug Metab Dispos; 2007 Jul; 35(7):1112-8. PubMed ID: 17420282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of 5-(4-acetamidophenyl)pyrazin-2(1H)-one in rat, dog and cynomolgus monkey.
    Ross DA; Osborne PM; Pue MA; Blake TJ; Chenery RJ; Metcalf R
    Xenobiotica; 1988 Dec; 18(12):1373-87. PubMed ID: 3245231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.